Paraoxonase and arylesterase levels in autoimmune thyroid diseases

References

• Zarković M. The role of oxidative stress on the pathogenesis of graves’ disease. J Thyroid Res 2012. doi:10.1155/2012/302537.
   PubMedGoogle Scholar
• Virion A, Michot JL, Deme D, Kaniewski J, Pommier J. NADPH-dependent H2O2 generation and peroxidase activity in thyroid particular fraction. Mol Cell Endocrinol 1984;36(1–2):95–105. doi: 10.1016/0303-7207(84)90088-1
   PubMed Web of Science ®Google Scholar
• Marcocci C, Leo M, Altea MA. Oxidative stress in graves’ disease. Eur Thyroid J 2012;1(2):80–7. doi: 10.1159/000337976
   PubMedGoogle Scholar
• Rostami R, Aghasi MR, Mohammadi A, Nourooz-Zadeh J. Enhanced oxidative stress in Hashimoto's thyroiditis: inter-relationships to biomarkers of thyroid function. Clin Biochem 2013;46(4–5):308–12. doi: 10.1016/j.clinbiochem.2012.11.021
   PubMed Web of Science ®Google Scholar
• Girotti AW. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res 1998;39:1529–42.
   PubMed Web of Science ®Google Scholar
• Miyamoto S, Di Mascio P. Lipid hydroperoxides as a source of singlet molecular oxygen. Subcell Biochem 2014;77:3–20. doi: 10.1007/978-94-007-7920-4_1
   PubMedGoogle Scholar
• Lassoued S, Mseddi M, Mnif F, Abid M, Guermazi F, Masmoudi H, et al. A comparative study of the oxidative profile in Graves’ disease, Hashimoto's thyroiditis, and papillary thyroid cancer. Biol Trace Elem Res 2010;138(1–3):107–15. doi: 10.1007/s12011-010-8625-1
   PubMed Web of Science ®Google Scholar
• Akarsu E, Buyukhatipoglu H, Aktaran S, Kurtul N. Effects of pulse methylprednisolone and oral methylprednisolone treatments on serum levels of oxidative stress markers in Graves’ ophthalmopathy. Clin Endocrinol (Oxf) 2011;74(1):118–24. doi: 10.1111/j.1365-2265.2010.03904.x
   PubMed Web of Science ®Google Scholar
• Rajkovic MG, Rumora L, Barisic K. The paraoxonase 1, 2 and 3 in humans. Biochem Med (Zagreb) 2011;21:122–30. doi: 10.11613/BM.2011.020
   PubMed Web of Science ®Google Scholar
• Baskol G, Demir H, Baskol M, Kilic E, Ates F, Kocer D, et al. Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis. Clin Biochem 2005;38(10):951–5. doi: 10.1016/j.clinbiochem.2005.06.010
   PubMed Web of Science ®Google Scholar
• Bodolay E, Seres I, Szodoray P, Csípo I, Jakab Z, Vegh J, et al. Evaluation of paraoxonase activity in patients with mixed connective tissue disease. J Rheumatol 2008;35(2):237–43.
   PubMed Web of Science ®Google Scholar
• Szántó A, Harangi M, Seres I, Paragh G, Zeher M. Decreased human paraoxonase-1 activity in patients with Sjögren's syndrome. Int Immunol 2010;22(7):605–9. doi: 10.1093/intimm/dxq045
   PubMed Web of Science ®Google Scholar
• Delgado Alves J, Ames PR, Donohue S, Stanyer L, Nourooz-Zadeh J, Ravirajan C, et al. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome. Arthritis Rheum 2002;46(10):2686–94. doi: 10.1002/art.10542
   PubMed Web of Science ®Google Scholar
• Arab K, Steghens JP. Plasma lipid hydroperoxides measurement by an automated xylenol orange method. Anal Biochem 2004;325(1):158–63. doi: 10.1016/j.ab.2003.10.022
   PubMed Web of Science ®Google Scholar
• Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82(1):70–7. doi: 10.1016/0003-9861(59)90090-6
   PubMed Web of Science ®Google Scholar
• Eckerson HW, Wyte MC, La Du BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1983;35(6):1126–38.
   PubMed Web of Science ®Google Scholar
• Haagen L, Brock A. A new automated method for phenotyping arylesterase (E.C.3.1.1.2.) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clin Biochem 1992;30(7):391–5.
   PubMedGoogle Scholar
• Eckerson HW, Wytw CM, La Du BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1983;35(6):1126–38.
   PubMed Web of Science ®Google Scholar
• Carvalho DP, Dupuy C. Role of the NADPH oxidases DUOX and NOX4 in thyroid oxidative stress. Eur Thyroid J 2013;2(3):160–7. doi: 10.1159/000354745
   PubMedGoogle Scholar
• Baser H, Can U, Baser S, Yerlikaya FH, Aslan U, Hidayetoglu BT. Assessment of oxidative status and its association with thyroid autoantibodies in patients with euthyroid autoimmune thyroiditis. Endocrine 2015;48(3):916–23. doi: 10.1007/s12020-014-0399-3
   PubMed Web of Science ®Google Scholar
• Niki E. Lipid peroxidation: physiological levels and dual biological effects. Free Radic Biol Med 2009;47(5):469–84. doi: 10.1016/j.freeradbiomed.2009.05.032
   PubMed Web of Science ®Google Scholar
• Catalá A. Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chem Phys Lipids 2009;157(1):1–11. doi: 10.1016/j.chemphyslip.2008.09.004
   PubMed Web of Science ®Google Scholar
• Yoshida Y, Umeno A, Shichiri M. Lipid peroxidation biomarkers for evaluating oxidative stress and assessing antioxidant capacity in vivo. J Clin Biochem Nutr 2013;52:9–16. doi: 10.3164/jcbn.12-112
   PubMed Web of Science ®Google Scholar
• Deakin SP, Bioletto S, Bochaton-Piallat ML, James RW. HDL-associated paraoxonase-1 can redistribute to cell membranes and influence sensitivity to oxidative stress. Free Radic Biol Med 2011;50(1):102–9. doi: 10.1016/j.freeradbiomed.2010.09.002
   PubMed Web of Science ®Google Scholar
• Précourt LP, Amre D, Denis MC, Lavoie JC, Delvin E, Seidman E, et al. The three-gene paraoxonase family: physiologic roles, actions and regulation. Atherosclerosis 2011;214(1):20–36. doi: 10.1016/j.atherosclerosis.2010.08.076
   PubMed Web of Science ®Google Scholar
• Turgay F, Sisman AR, Aksu AC. Effects of anaerobic training on paraoxonase-1 enzyme (PON1) activities of high density lipoprotein subgroups and its relationship with PON1–Q192R phenotype. J Atheroscler Tromb 2015;22(3):313–26. doi: 10.5551/jat.25809
   PubMed Web of Science ®Google Scholar